Literature DB >> 25737393

Analysis for Genetic Modifiers of Disease Severity in Patients With Long-QT Syndrome Type 2.

Iris C R M Kolder1, Michael W T Tanck1, Pieter G Postema1, Jean-Jacques Schott1, Eric Schulze-Bahr1, Connie R Bezzina1, Julien Barc1, Moritz F Sinner1, Sven Zumhagen1, Anja Husemann1, Birgit Stallmeyer1, Tamara T Koopmann1, Nynke Hofman1, Arne Pfeufer1, Peter Lichtner1, Thomas Meitinger1, Britt M Beckmann1, Robert J Myerburg1, Nanette H Bishopric1, Dan M Roden1, Stefan Kääb1, Arthur A M Wilde1.   

Abstract

BACKGROUND: Considerable interest exists in the identification of genetic modifiers of disease severity in the long-QT syndrome (LQTS) as their identification may contribute to refinement of risk stratification. METHODS AND
RESULTS: We searched for single-nucleotide polymorphisms (SNPs) that modulate the corrected QT (QTc)-interval and the occurrence of cardiac events in 639 patients harboring different mutations in KCNH2. We analyzed 1201 SNPs in and around 18 candidate genes, and in another approach investigated 22 independent SNPs previously identified as modulators of QTc-interval in genome-wide association studies in the general population. In an analysis for quantitative effects on the QTc-interval, 3 independent SNPs at NOS1AP (rs10494366, P=9.5×10(-8); rs12143842, P=4.8×10(-7); and rs2880058, P=8.6×10(-7)) were strongly associated with the QTc-interval with marked effects (>12 ms/allele). Analysis of patients versus general population controls uncovered enrichment of QTc-prolonging alleles in patients for 2 SNPs, located respectively at NOS1AP (rs12029454; odds ratio, 1.85; 95% confidence interval, 1.32-2.59; P=3×10(-4)) and KCNQ1 (rs12576239; odds ratio, 1.84; 95% confidence interval, 1.31-2.60; P=5×10(-4)). An analysis of the cumulative effect of the 6 NOS1AP SNPs by means of a multilocus genetic risk score (GRS(NOS1AP)) uncovered a strong linear relationship between GRS(NOS1AP) and the QTc-interval (P=4.2×10(-7)). Furthermore, patients with a GRS(NOS1AP) in the lowest quartile had a lower relative risk of cardiac events compared with patients in the other quartiles combined (P=0.039).
CONCLUSIONS: We uncovered unexpectedly large effects of NOS1AP SNPs on the QTc-interval and a trend for effects on risk of cardiac events. For the first time, we linked common genetic variation at KCNQ1 with risk of long-QT syndrome.
© 2015 American Heart Association, Inc.

Entities:  

Keywords:  arrhythmias, cardiac; ion channels; long-QT syndrome

Mesh:

Substances:

Year:  2015        PMID: 25737393      PMCID: PMC4770255          DOI: 10.1161/CIRCGENETICS.114.000785

Source DB:  PubMed          Journal:  Circ Cardiovasc Genet        ISSN: 1942-3268


  20 in total

1.  Polymorphisms in the NOS1AP gene modulate QT interval duration and risk of arrhythmias in the long QT syndrome.

Authors:  Marta Tomás; Carlo Napolitano; Luciana De Giuli; Raffaella Bloise; Isaac Subirana; Alberto Malovini; Riccardo Bellazzi; Dan E Arking; Eduardo Marban; Aravinda Chakravarti; Peter M Spooner; Silvia G Priori
Journal:  J Am Coll Cardiol       Date:  2010-06-15       Impact factor: 24.094

2.  Identification of a KCNQ1 polymorphism acting as a protective modifier against arrhythmic risk in long-QT syndrome.

Authors:  Sabine Duchatelet; Lia Crotti; Rachel A Peat; Isabelle Denjoy; Hideki Itoh; Myriam Berthet; Seiko Ohno; Véronique Fressart; Maria Cristina Monti; Cristina Crocamo; Matteo Pedrazzini; Federica Dagradi; Alessandro Vicentini; Didier Klug; Paul A Brink; Althea Goosen; Heikki Swan; Lauri Toivonen; Annukka M Lahtinen; Kimmo Kontula; Wataru Shimizu; Minoru Horie; Alfred L George; David-Alexandre Trégouët; Pascale Guicheney; Peter J Schwartz
Journal:  Circ Cardiovasc Genet       Date:  2013-07-15

Review 3.  Impact of genetics on the clinical management of channelopathies.

Authors:  Peter J Schwartz; Michael J Ackerman; Alfred L George; Arthur A M Wilde
Journal:  J Am Coll Cardiol       Date:  2013-05-15       Impact factor: 24.094

4.  NOS1AP is a genetic modifier of the long-QT syndrome.

Authors:  Lia Crotti; Maria Cristina Monti; Roberto Insolia; Anna Peljto; Althea Goosen; Paul A Brink; David A Greenberg; Peter J Schwartz; Alfred L George
Journal:  Circulation       Date:  2009-10-12       Impact factor: 29.690

5.  Genetic variation in SCN10A influences cardiac conduction.

Authors:  John C Chambers; Jing Zhao; Cesare M N Terracciano; Connie R Bezzina; Weihua Zhang; Riyaz Kaba; Manoraj Navaratnarajah; Amol Lotlikar; Joban S Sehmi; Manraj K Kooner; Guohong Deng; Urszula Siedlecka; Saurabh Parasramka; Ismail El-Hamamsy; Mark N Wass; Lukas R C Dekker; Jonas S S G de Jong; Michael J E Sternberg; William McKenna; Nicholas J Severs; Ranil de Silva; Arthur A M Wilde; Praveen Anand; Magdi Yacoub; James Scott; Paul Elliott; John N Wood; Jaspal S Kooner
Journal:  Nat Genet       Date:  2010-01-10       Impact factor: 38.330

6.  Common variants at ten loci modulate the QT interval duration in the QTSCD Study.

Authors:  Arne Pfeufer; Serena Sanna; Dan E Arking; Martina Müller; Vesela Gateva; Christian Fuchsberger; Georg B Ehret; Marco Orrú; Cristian Pattaro; Anna Köttgen; Siegfried Perz; Gianluca Usala; Maja Barbalic; Man Li; Benno Pütz; Angelo Scuteri; Ronald J Prineas; Moritz F Sinner; Christian Gieger; Samer S Najjar; W H Linda Kao; Thomas W Mühleisen; Mariano Dei; Christine Happle; Stefan Möhlenkamp; Laura Crisponi; Raimund Erbel; Karl-Heinz Jöckel; Silvia Naitza; Gerhard Steinbeck; Fabio Marroni; Andrew A Hicks; Edward Lakatta; Bertram Müller-Myhsok; Peter P Pramstaller; H-Erich Wichmann; David Schlessinger; Eric Boerwinkle; Thomas Meitinger; Manuela Uda; Josef Coresh; Stefan Kääb; Gonçalo R Abecasis; Aravinda Chakravarti
Journal:  Nat Genet       Date:  2009-03-22       Impact factor: 38.330

7.  Variants in the 3' untranslated region of the KCNQ1-encoded Kv7.1 potassium channel modify disease severity in patients with type 1 long QT syndrome in an allele-specific manner.

Authors:  Ahmad S Amin; John R Giudicessi; Anke J Tijsen; Anne M Spanjaart; Yolan J Reckman; Christine A Klemens; Michael W Tanck; Jamie D Kapplinger; Nynke Hofman; Moritz F Sinner; Martina Müller; Wino J Wijnen; Hanno L Tan; Connie R Bezzina; Esther E Creemers; Arthur A M Wilde; Michael J Ackerman; Yigal M Pinto
Journal:  Eur Heart J       Date:  2011-12-23       Impact factor: 29.983

8.  Common variants at SCN5A-SCN10A and HEY2 are associated with Brugada syndrome, a rare disease with high risk of sudden cardiac death.

Authors:  Connie R Bezzina; Julien Barc; Yuka Mizusawa; Carol Ann Remme; Jean-Baptiste Gourraud; Floriane Simonet; Arie O Verkerk; Peter J Schwartz; Lia Crotti; Federica Dagradi; Pascale Guicheney; Véronique Fressart; Antoine Leenhardt; Charles Antzelevitch; Susan Bartkowiak; Martin Borggrefe; Rainer Schimpf; Eric Schulze-Bahr; Sven Zumhagen; Elijah R Behr; Rachel Bastiaenen; Jacob Tfelt-Hansen; Morten Salling Olesen; Stefan Kääb; Britt M Beckmann; Peter Weeke; Hiroshi Watanabe; Naoto Endo; Tohru Minamino; Minoru Horie; Seiko Ohno; Kanae Hasegawa; Naomasa Makita; Akihiko Nogami; Wataru Shimizu; Takeshi Aiba; Philippe Froguel; Beverley Balkau; Olivier Lantieri; Margherita Torchio; Cornelia Wiese; David Weber; Rianne Wolswinkel; Ruben Coronel; Bas J Boukens; Stéphane Bézieau; Eric Charpentier; Stéphanie Chatel; Aurore Despres; Françoise Gros; Florence Kyndt; Simon Lecointe; Pierre Lindenbaum; Vincent Portero; Jade Violleau; Manfred Gessler; Hanno L Tan; Dan M Roden; Vincent M Christoffels; Hervé Le Marec; Arthur A Wilde; Vincent Probst; Jean-Jacques Schott; Christian Dina; Richard Redon
Journal:  Nat Genet       Date:  2013-07-21       Impact factor: 38.330

9.  The Genome of the Netherlands: design, and project goals.

Authors:  Dorret I Boomsma; Cisca Wijmenga; Eline P Slagboom; Morris A Swertz; Lennart C Karssen; Abdel Abdellaoui; Kai Ye; Victor Guryev; Martijn Vermaat; Freerk van Dijk; Laurent C Francioli; Jouke Jan Hottenga; Jeroen F J Laros; Qibin Li; Yingrui Li; Hongzhi Cao; Ruoyan Chen; Yuanping Du; Ning Li; Sujie Cao; Jessica van Setten; Androniki Menelaou; Sara L Pulit; Jayne Y Hehir-Kwa; Marian Beekman; Clara C Elbers; Heorhiy Byelas; Anton J M de Craen; Patrick Deelen; Martijn Dijkstra; Johan T den Dunnen; Peter de Knijff; Jeanine Houwing-Duistermaat; Vyacheslav Koval; Karol Estrada; Albert Hofman; Alexandros Kanterakis; David van Enckevort; Hailiang Mai; Mathijs Kattenberg; Elisabeth M van Leeuwen; Pieter B T Neerincx; Ben Oostra; Fernanodo Rivadeneira; Eka H D Suchiman; Andre G Uitterlinden; Gonneke Willemsen; Bruce H Wolffenbuttel; Jun Wang; Paul I W de Bakker; Gert-Jan van Ommen; Cornelia M van Duijn
Journal:  Eur J Hum Genet       Date:  2013-05-29       Impact factor: 4.246

10.  A genome-wide association scan of RR and QT interval duration in 3 European genetically isolated populations: the EUROSPAN project.

Authors:  Fabio Marroni; Arne Pfeufer; Yurii S Aulchenko; Christopher S Franklin; Aaron Isaacs; Irene Pichler; Sarah H Wild; Ben A Oostra; Alan F Wright; Harry Campbell; Jacqueline C Witteman; Stefan Kääb; Andrew A Hicks; Ulf Gyllensten; Igor Rudan; Thomas Meitinger; Cristian Pattaro; Cornelia M van Duijn; James F Wilson; Peter P Pramstaller
Journal:  Circ Cardiovasc Genet       Date:  2009-05-15
View more
  17 in total

1.  The role of known variants of KCNQ1, KCNH2, KCNE1, SCN5A, and NOS1AP in water-related deaths.

Authors:  Iliana Tzimas; Jana-Christin Zingraf; Thomas Bajanowski; Micaela Poetsch
Journal:  Int J Legal Med       Date:  2016-07-26       Impact factor: 2.686

Review 2.  Nitric oxide signalling in cardiovascular health and disease.

Authors:  Charlotte Farah; Lauriane Y M Michel; Jean-Luc Balligand
Journal:  Nat Rev Cardiol       Date:  2018-02-01       Impact factor: 32.419

Review 3.  Genetics of long-QT syndrome.

Authors:  Yukiko Nakano; Wataru Shimizu
Journal:  J Hum Genet       Date:  2015-06-25       Impact factor: 3.172

Review 4.  Beyond the One Gene-One Disease Paradigm: Complex Genetics and Pleiotropy in Inheritable Cardiac Disorders

Authors:  Marina Cerrone; Carol Ann Remme; Rafik Tadros; Connie R Bezzina; Mario Delmar
Journal:  Circulation       Date:  2019-08-12       Impact factor: 29.690

Review 5.  The Advantages, Challenges, and Future of Human-Induced Pluripotent Stem Cell Lines in Type 2 Long QT Syndrome.

Authors:  Dihui Cai; Zequn Zheng; Xiaojun Jin; Yin Fu; Lichao Cen; Jiachun Ye; Yongfei Song; Jiangfang Lian
Journal:  J Cardiovasc Transl Res       Date:  2022-08-17       Impact factor: 3.216

6.  Semiconductor Whole Exome Sequencing for the Identification of Genetic Variants in Colombian Patients Clinically Diagnosed with Long QT Syndrome.

Authors:  Mariana Burgos; Alvaro Arenas; Rodrigo Cabrera
Journal:  Mol Diagn Ther       Date:  2016-08       Impact factor: 4.074

7.  Long QT syndrome: how effective therapy in a single patient favorably influenced the long-term clinical course and genetic understanding of this hereditary disorder.

Authors:  Katherine M Lowengrub; Deborah R Moss; David A Moss; Arthur J Moss
Journal:  Prog Cardiovasc Dis       Date:  2015-08-04       Impact factor: 8.194

Review 8.  Ventricular repolarization measures for arrhythmic risk stratification.

Authors:  Francesco Monitillo; Marta Leone; Caterina Rizzo; Andrea Passantino; Massimo Iacoviello
Journal:  World J Cardiol       Date:  2016-01-26

Review 9.  Modifier genes for sudden cardiac death.

Authors:  Peter J Schwartz; Lia Crotti; Alfred L George
Journal:  Eur Heart J       Date:  2018-11-21       Impact factor: 35.855

Review 10.  Human Induced Pluripotent Stem Cell-Derived Cardiomyocytes Afford New Opportunities in Inherited Cardiovascular Disease Modeling.

Authors:  Daniel R Bayzigitov; Sergey P Medvedev; Elena V Dementyeva; Sevda A Bayramova; Evgeny A Pokushalov; Alexander M Karaskov; Suren M Zakian
Journal:  Cardiol Res Pract       Date:  2016-03-27       Impact factor: 1.866

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.